A detailed history of Fmr LLC transactions in Incyte Corp stock. As of the latest transaction made, Fmr LLC holds 1,787,408 shares of INCY stock, worth $136 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,787,408
Previous 1,623,902 10.07%
Holding current value
$136 Million
Previous $92.5 Million 17.12%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $8.37 Million - $10.4 Million
163,506 Added 10.07%
1,787,408 $108 Million
Q1 2024

May 13, 2024

BUY
$56.55 - $66.59 $16.6 Million - $19.6 Million
293,783 Added 22.09%
1,623,902 $92.5 Million
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $11.8 Million - $14.5 Million
-226,632 Reduced 14.56%
1,330,119 $83.5 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $24.8 Million - $28.4 Million
430,121 Added 38.18%
1,556,751 $89.9 Million
Q2 2023

Aug 11, 2023

SELL
$60.95 - $75.51 $3.94 Million - $4.88 Million
-64,663 Reduced 5.43%
1,126,630 $70.1 Million
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $10 Million - $12.3 Million
142,584 Added 13.6%
1,191,293 $86.1 Million
Q4 2022

Feb 13, 2023

SELL
$67.18 - $84.11 $5.23 Million - $6.55 Million
-77,898 Reduced 6.91%
1,048,709 $84.2 Million
Q3 2022

Nov 10, 2022

BUY
$66.18 - $82.86 $148,905 - $186,435
2,250 Added 0.2%
1,126,607 $75.1 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $30.8 Million - $38.7 Million
465,185 Added 70.57%
1,124,357 $85.4 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $19.8 Million - $24 Million
300,650 Added 83.86%
659,172 $52.4 Million
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $1.07 Million - $1.26 Million
-16,946 Reduced 4.51%
358,522 $26.3 Million
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $29.3 Million - $35.8 Million
-426,266 Reduced 53.17%
375,468 $0
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $64 Million - $70.2 Million
801,734 New
801,734 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.